Benefit of platanus and Rosemary extract on treatment of resistant asthma
Phase 2
- Conditions
- Asthma.Asthma, unspecified
- Registration Number
- IRCT201107312695N2
- Lead Sponsor
- Vice chancellor for research, Islamic Azad University- Mashhad Branch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1- Resistant asthma to Inhaled corticosteroid, long acting beta 2 agonist, antileukotrien and theophyllin Exclusion criteria: 1- Respiratory infection 2- Fair Treatment with controller drugs 3- Not cooperative with project 4- congestive heart failure 5- Gastroesophageal reflux 6- Rhinosinusitis, 7- pregnancy 8- smoking 9- non asthmatic other lung disease and non pulmonary disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1. Timepoint: before treatment and one month after treatment. Method of measurement: spirometry superspiro, Micromedical company, England.;Exhaled Nitric oxide (FENO). Timepoint: before treatment and one month after treatment. Method of measurement: Chemiluminescence instrument, No Breath, Bedfont company, England.;ACT Questionnaire. Timepoint: before treatment and one month after treatment. Method of measurement: Validated Asthma control test Questionnaire.
- Secondary Outcome Measures
Name Time Method IL-17. Timepoint: Before treatment and One month after treatment. Method of measurement: ELIZA- Qiagen company Tehran Iran.;INF- Gamma. Timepoint: Before treatment and One month after treatment. Method of measurement: ELIZA- Qiagen company Tehran Iran.